News & Analysis on Clinical Trial Services & Contract Research And Development
Switzerland's Solvias AG, a specialist in scientific and technical services and products based on synthesis and analysis, has reported a healthy 20 per cent hike in 2002 sales to SF43.6 million (€28.6m). The increase was driven largely by Solvias'...
US pharmaceutical major Eli Lilly has earmarked a hefty £220 million (€304 million) investment over the next four years in its UK facilities, representing the largest investment by the firm in any European country.
US pharmaceutical major Pfizer reinforced its position as the world's largest drug company in 2002 after putting in sales of $29.45 billion (€25.12 bn) in 2002, a hike of 11 per cent over the prior year, according to a new analysis by IMS Health. And...
The European Commission has given the go-ahead for Germany to grant a proposed €78 million in aid to help Merck KGaA build a new biopharmaceuticals plant for the production of oncology products in Jena, Thuringen.